These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3254828)

  • 1. Introductory remarks: symposium on pinacidil: potassium channel openers in the treatment of hypertension.
    Weston AH
    Drugs; 1988; 36 Suppl 7():1-3. PubMed ID: 3254828
    [No Abstract]   [Full Text] [Related]  

  • 2. Pinacidil: potassium channel openers in the treatment of hypertension. Proceedings of a symposium. Copenhagen, 10-11 March, 1988.
    Drugs; 1988; 36 Suppl 7():1-98. PubMed ID: 3254829
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
    Atwal KS
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S12-7. PubMed ID: 7898103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Potassium channel openers. A new possible therapeutic principle in several diseases].
    Drottning P; Christensen H; Storstein L
    Tidsskr Nor Laegeforen; 1994 Feb; 114(4):450-3. PubMed ID: 8009483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of pinacidil, a prototype for drugs that affect potassium channels.
    Goldberg MR
    J Cardiovasc Pharmacol; 1988; 12 Suppl 2():S41-7. PubMed ID: 2466178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.
    Friedel HA; Brogden RN
    Drugs; 1990 Jun; 39(6):929-67. PubMed ID: 2196168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of N-(6-functionalized-amino-3-pyridyl)-N'-bicycloalkyl-N''-cyanoguanidine s as antihypertensive agents.
    Eda M; Takemoto T; Okada T; Sakashita H; Matzno S; Gohda M; Hayashi K; Nakamura N; Fukaya C
    Chem Pharm Bull (Tokyo); 1996 Feb; 44(2):307-13. PubMed ID: 8998837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K(+)-channel openers: new antihypertensive drugs?
    Haeusler G
    Clin Physiol Biochem; 1990; 8 Suppl 2():46-56. PubMed ID: 2095310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparator trials with pinacidil, a potassium channel opener.
    Callaghan JT; Goldberg MR; Brunelle R
    Drugs; 1988; 36 Suppl 7():77-82. PubMed ID: 3076139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium channel openers increase aortic elastic fiber formation and reverse the genetically determined elastin deficit in the BN rat.
    Slove S; Lannoy M; Behmoaras J; Pezet M; Sloboda N; Lacolley P; Escoubet B; Buján J; Jacob MP
    Hypertension; 2013 Oct; 62(4):794-801. PubMed ID: 23918751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of pinacidil, a potassium channel opener, in hypertension.
    Goldberg MR; Rockhold FW; Thompson WL; DeSante KA
    J Clin Pharmacol; 1989 Jan; 29(1):33-40. PubMed ID: 2708546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ion channel effects of pinacidil in vascular muscle.
    Hermsmeyer K
    Drugs; 1988; 36 Suppl 7():29-32. PubMed ID: 2474427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR analysis of tautomerisms of active pinacidil-type potassium channel openers and a less active one.
    Yoshiizumi K; Nakajima F; Kiyoi T; Kondo H
    Bioorg Med Chem Lett; 2000 Nov; 10(21):2463-6. PubMed ID: 11078201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of the potassium channel openers cromakalim and pinacidil and the cromakalim analog U-89232 on isolated vascular and cardiac tissue.
    Norman NR; Toombs CF; Khan SA; Buchanan LV; Cimini MG; Gibson JK; Meisheri KD; Shebuski RJ
    Pharmacology; 1994 Aug; 49(2):86-95. PubMed ID: 7972325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium channels and human corporeal smooth muscle cell tone: diabetes and relaxation of human corpus cavernosum smooth muscle by adenosine triphosphate sensitive potassium channel openers.
    Venkateswarlu K; Giraldi A; Zhao W; Wang HZ; Melman A; Spektor M; Christ GJ
    J Urol; 2002 Jul; 168(1):355-61. PubMed ID: 12050569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Potassium channel activators. Perspectives in the treatment of arterial hypertension].
    Giudicelli JF; Richer C; Berdeaux A
    Presse Med; 1991 Jan; 20(2):75-81. PubMed ID: 1825708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.
    Shindo T; Yamada M; Isomoto S; Horio Y; Kurachi Y
    Br J Pharmacol; 1998 Jul; 124(5):985-91. PubMed ID: 9692785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of potassium channels in vascular relaxation. Proceedings of a symposium on pinacidil. Indianapolis, Indiana, June 25, 1987.
    J Cardiovasc Pharmacol; 1988; 12 Suppl 2():S1-47. PubMed ID: 2466173
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of pinacidil on bladder muscle.
    Andersson KE; Andersson PO; Fovaeus M; Hedlund H; Malmgren A; Sjögren C
    Drugs; 1988; 36 Suppl 7():41-9. PubMed ID: 3076135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium channel modulation: effect of pinacidil on insulin release in healthy volunteers.
    Links TP; Smit AJ; Reitsma WD
    J Clin Pharmacol; 1995 Mar; 35(3):291-4. PubMed ID: 7608319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.